3 Biotech Stocks a Pro Is Buying Now (Barron’s)
The last time we checked in with Joseph Edelman, the founder, chief executive and portfolio manager of Perceptive Advisors and its hedge fund, Perceptive Life Sciences, he was buying stocks ahead of the new year. Perceptive is a fund to watch. Edelman famously oversaw a 4% gain in 2016 as the biotech sector tumbled 20%. Perceptive soared over 43% in 2017, more than doubling the 20% gain in the Standard & Poor’s 500 Index and the 21% gain in the Nasdaq Biotechnology Index. What stocks are Edelman, and his chief investment officer, Adam Stone, buying now? Earlier this month, Perceptive unveiled larger stakes in Agile Therapeutics (AGRX), La Jolla Pharmaceutical (LJPC) and Amicus Therapeutics (FOLD).
Tesla’s ‘Day of Reckoning’ is Near as its Plunging Stock Increases Financing Risk (CNBC)
One hedge fund manager believes Tesla’s business model is permanently broken. “Tesla represents a financially non-viable business. It has an upside-down balance sheet. The multi-billion cash burn is massive with no end in sight,” Accipiter Capital‘s Gabe Hoffman wrote in an email Wednesday. “The financial need for Tesla to issue massive amounts of new equity has been glaringly obvious for quite some time.”
Image By Monkey Business – Adobe
All Eddie Lampert Needs To Save Sears Is Another Couple Hundred Long Articles Depicting Him As An Awkward Weirdo Selling The Company For Parts (DealBreaker)
Here are some excerpts from Vanity Fair’s long profile of Eddie Lampert and the less-than-bang-up job he’s done with Sears. “He’s so obsessed with moving in the direction he wants to move that sometimes people get burned, trampled on, bumped into,” Rainwater said of Lampert. “I think he has gone about alienating himself from almost everyone who he’s come into contact with.”
Michael Hintze: Every Crisis Is a Trading Opportunity (Barron’s)
There are many reasons to heed Sir Michael Hintze; the fact that he’s a billionaire is only one. At 64, Hintze has lived several lives. He was an officer in the Australian Army and an electrical engineer, and now manages CQS Cayman LP, a $15.3 billion London-based hedge-fund firm that he founded in 1999. The firm has performed admirably through multiple market dust-ups, and famously weathered the 2008 market wipe-out with a 72.8% return in its asset-backed securities fund…
Insider Buying: EntreMed, Inc. (NASDAQ:CASI) Director Buys 3,086,419 Shares of Stock (RegistrarJournal.com)
EntreMed, Inc. (NASDAQ:CASI) Director Wei-Wu He bought 3,086,419 shares of the stock in a transaction on Monday, March 19th. The shares were bought at an average price of $3.24 per share, for a total transaction of $9,999,997.56. Following the purchase, the director now directly owns 847,527 shares in the company, valued at approximately $2,745,987.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.
Insider Buying: WideOpenWest Inc (NYSE:WOW) Director Purchases 1,456,767 Shares of Stock (MaconDaily.com)
WideOpenWest Inc (NYSE:WOW) Director Crestview Partners Iii Gp, L.P purchased 1,456,767 shares of the business’s stock in a transaction dated Wednesday, March 21st. The shares were purchased at an average price of $7.19 per share, for a total transaction of $10,474,154.73. The purchase was disclosed in a filing with the SEC.
Insider Buying: National CineMedia, Inc. (NCMI) Major Shareholder Acquires 249,600 Shares of Stock (RegistrarJournal.com)
National CineMedia, Inc. (NASDAQ:NCMI) major shareholder General L.P. Standard bought 249,600 shares of the stock in a transaction that occurred on Friday, March 16th. The stock was bought at an average cost of $5.74 per share, for a total transaction of $1,432,704.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Insider Buying: Enterprise Products Partners L.P. (EPD) CEO Buys 20,000 Shares of Stock (LedgerGazette.com)
Enterprise Products Partners L.P. (NYSE:EPD) CEO Aj Teague acquired 20,000 shares of the company’s stock in a transaction dated Wednesday, March 7th. The shares were purchased at an average price of $24.86 per share, with a total value of $497,200.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission.
At Home Group Inc (HOME) Insider Sells $413,852.00 in Stock (StockNewsTimes.com)
At Home Group Inc (NYSE:HOME) insider Norman E. Mcleod sold 12,560 shares of the business’s stock in a transaction on Friday, March 23rd. The shares were sold at an average price of $32.95, for a total transaction of $413,852.00. Following the transaction, the insider now owns 14,827 shares in the company, valued at approximately $488,549.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Insider Buying: Zynerba Pharmaceuticals (ZYNE) Major Shareholder Buys 10,000 Shares of Stock (MaconDaily.com)
Zynerba Pharmaceuticals (NASDAQ:ZYNE) major shareholder Michael Rapp acquired 10,000 shares of Zynerba Pharmaceuticals stock in a transaction on Thursday, March 22nd. The shares were purchased at an average cost of $9.28 per share, for a total transaction of $92,800.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
